BCL6 and diffuse large B-cell lymphoma: We further note that because CoRec assays endogenous proteins, it provides a straightforward method to profile the impact of cell-specific mutations on TF–COF interactions and DNA binding, as exemplified by the BCL6–TBL1XR1 interactions in DLBCL subtypes.